ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
Dow Jones
38,239.66
0.40%
Brent Oil
88.165
0.00%
Bitcoin
62,955.53
-1.23%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Harmony Biosciences Holdings Inc (HRMY) Quote

Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc (HRMY)

NASDAQ
29.32
0.39
(1.35%)
Closed April 27 4:00PM
Delayed by 15 minutes
29.32
0.00
(0.00%)
After Hours: 7:58PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
29.32
Bid
29.00
Ask
30.37
Volume
376,165
29.00 Day's Range 30.14
18.6112 52 Week Range 39.265
Market Cap
1.666B
Previous Close
28.93
Open
29.00
Last Trade
274
@
29.32
(formt)
Last Trade Time
Financial Volume
$ 11,134,321
VWAP
29.5996
Average Volume (3m)
382,621
Shares Outstanding
56,769,081
Dividend Yield
-
PE Ratio
12.93
Earnings Per Share (EPS)
2.27
Revenue
582.02M
Net Profit
128.85M

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action spe... Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.harmonybiosciences.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Harmony Biosciences Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HRMY. The last closing price for Harmony Biosciences was $28.93. Over the last year, Harmony Biosciences shares have traded in a share price range of $ 18.6112 to $ 39.265.

Harmony Biosciences currently has 56,769,081 shares outstanding. The market capitalization of Harmony Biosciences is $1.67 billion. Harmony Biosciences has a price to earnings ratio (PE ratio) of 12.93.

HRMY Latest News

More News

HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024

HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024 PR Newswire PLYMOUTH MEETING, Pa., April 16, 2024 PLYMOUTH MEETING, Pa., April 16, 2024 /PRNewswire/...

April 16 2024
PR Newswire (US)

HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST

HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST TPM-1116 preclinical data suggest a potential...

April 11 2024
PR Newswire (US)

HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME

HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME Trial initiation a step toward potentially treating excessive...

April 03 2024
PR Newswire (US)

HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE

HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE PR Newswire PLYMOUTH MEETING, Pa., March 26, 2024 PLYMOUTH MEETING, Pa., March 26, 2024 /PRNewswire/...

March 26 2024
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

March 11 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

March 08 2024
Edgar (US Regulatory)

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

February 28 2024
Edgar (US Regulatory)

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES PR Newswire PLYMOUTH MEETING, Pa., Feb. 28, 2024 PLYMOUTH MEETING, Pa., Feb. 28, 2024 /PRNewswire/ -- Harmony Biosciences...

February 28 2024
PR Newswire (US)

Form S-8 - Securities to be offered to employees in employee benefit plans

February 22 2024
Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

February 22 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.571.9826086956528.7530.1428.1435940929.14428564CS
4-4.76-13.967136150234.0834.0828.1438988830.08974895CS
12-1.86-5.965362411831.1835.39528.1438262131.49566556CS
269.8650.66803699919.4635.39519.0345761829.98333452CS
52-2.49-7.8277271298331.8139.26518.611254244631.26324196CS
1561.13.8979447200628.2262.08518.611251844538.72700876CS
260-7.18-19.671232876736.562.08518.611245431238.58239374CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

Discussion

View Full Feed
StayHumble StayHumble 1 minute ago
10km00t🔥8km00t🔥ALJm00t 47Wins
JudgeFAV0RED$DBMM. Meaning the ruling? +1
Source: https://www.sec.gov/alj/aljdec/2019/id1389cff.pdf
No available sanction appropriate|Thus Proceeding Dismissed.
-------------------------------V. ORDER----------------
DBMM
bio33 bio33 1 minute ago
based on 41.8$M raised from the conversion they got 3.26$/sh on the 12.8M shares they sold
M
Gmenfan Gmenfan 2 minutes ago
The week in whoppers: The Squad’s Cori Bush flips reality on protests, NY Times begs for Trump’s conviction and more
By Post Editorial Board Published April 25, 2024, 6:15 p.m. ET

Diary of disturbing disinformation and dangerous delusions
This tweet:

https
Gmenfan Gmenfan 2 minutes ago
The week in whoppers: The Squad’s Cori Bush flips reality on protests, NY Times begs for Trump’s conviction and more
By Post Editorial Board Published April 25, 2024, 6:15 p.m. ET

Diary of disturbing disinformation and dangerous delusions
This tweet:

https
WALLnut WALLnut 2 minutes ago
Or they forgave me. People do that.



RDGL
RDGL
uksausage uksausage 3 minutes ago
this is good news for PLUG and many other companies.
no just finalize the 45V credits so we can convert them to cash
PLUG
Bubae Bubae 4 minutes ago
We al now that your two cents has been consistently wrong since this was trading above a penny. How about a few facts with links. GS Capital has the contract and appears to hold all the cards in this lawsuit. The pressure to settle is all on Blackstar's and the consequences are so egregious that Bla
BEGI
Wehalls Wehalls 4 minutes ago
Excellent
PVCT
CleverAces CleverAces 4 minutes ago
I really dont think we are done.
I am getting the sense that management and the board never expected to be in the position where they would run out of cash. All was smooth sailing, private placement in play, then everyone got blindsided by one or maybe more investors pulling out of the privat
SEV
frrol frrol 4 minutes ago
The past few years the EMA have had huge demand on their AD rapporteur roster. They're currently assessing lecanemab and donanemab, and they've been dragging on. Wouldn't be surprised if that was a factor in delay. Lecan is having procedural issues, and donan was being assessed for accelerated asses
AVXL
Robert31 Robert31 5 minutes ago
https://www.thestreet.com/investing/stocks/nvidia-set-to-capture-billions-as-microsoft-google-and-meta-boost-ai-spending?utm_source=flipboard&utm_content=topic%2Ftechnology
SEV
Real McCoy Real McCoy 8 minutes ago
Dismissed.

You’re out 100% and childishly making up fantasies. If you make em up, you’ll get called out - and I cannot possible lose because obviously nothing is happening.

Don’t care about you’re feelings, especially when you’re lying.

Accept when you’r
ralphey ralphey 9 minutes ago
Another Amazing Opportunity for AMRN ! The Pink market is the easiest exchange to get listed on. All a company needs to do is submit electronic Form 211, which is provided by the Financial Industry Regulatory Authority (FINRA). Usually, this is done on behalf of a company by a market maker.
AMRN
Zardiw Zardiw 9 minutes ago
World Situation Summary:

Starts at 2:03

https://www.youtube.com/watch?v=YfK79Hy9ieU

Z
train21 train21 12 minutes ago
brenda hamilton well known attorney for dead or undead tickers ?????
INCT
Heel Hulk Heel Hulk 13 minutes ago
You’re late. A friendly reminder if you want to continue under our employ.
You sleep when we sleep. You wake when we wake. If you’re early, you’re on time. If you’re on time, you’re late. If you’re late, you’re fired.
Don’t let it happen again. Take some time today to outshine iglow
Zardiw Zardiw 13 minutes ago
World Situation Summary:

Starts at 2:03

https://www.youtube.com/watch?v=YfK79Hy9ieU

Z
Zardiw Zardiw 14 minutes ago
Ironic that america is incapable of holding fair elections huh?..........lol

Z
domainmaster domainmaster 14 minutes ago
Another move that backfired on the Yankees

The Yankees dropped Cody Morris to free up a roster spot for reliever Michael Tonkin, who was claimed off waivers from the Mets earlier Thursday.

Clay Holmes breezed through three batters in the bottom of the ninth inning Frida
Zardiw Zardiw 15 minutes ago
The Woke Greenies?..........I wish they were getting delisted.......lol

Z
PEGY
Investor2014 Investor2014 16 minutes ago
Probably not, but I would recommend this wonderful rendition of the story:

https://youtu.be/WK_dkBC_Cno?si=4BPZW7mqz8LlKfuF
AVXL
train21 train21 16 minutes ago
the letter specifically mentions pa. ??
did someone file something in PA against INCT or is it the MARTINS gonna do some business in PA ??
INCT
tulla236a tulla236a 16 minutes ago
interesting. only 1/6 of the offering has been sold. is aa waiting for the squeeze?

https://www.businesswire.com/news/home/20240426331252/en/AMC-Entertainment-Holdings-Inc.-Previews-First-Quarter-2024-Preliminary-Results-and-Announces-First-Quarter-2024-Earnings-Webcast
AMC
runncoach runncoach 16 minutes ago
Probably the best financing agreement I have seen on one of these alternative AD plays. Seemingly shows a lot of confidence in the upcoming results.
ANVS

Your Recent History

NASDAQ
HRMY
Harmony Biosciences
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved